Related Experiment Video
Updated: Feb 15, 2026

Author Spotlight: Understanding Rhamnolipid Regulation in Pseudomonas aeruginosa
Published on: March 29, 2024
Molecular Insights into Function and Competitive Inhibition of Pseudomonas aeruginosa Multiple Virulence Factor
Tomoe Kitao1,2,3, Francois Lepine4, Seda Babloudi1
1Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Abstract:
New approaches to antimicrobial drug discovery are urgently needed to combat intractable infections caused by multidrug-resistant (MDR) bacteria. Multiple virulence factor regulator (MvfR or PqsR), a Pseudomonas aeruginosa quorum sensing transcription factor, regulates functions important in both acute and persistent infections. Recently identified non-ligand-based benzamine-benzimidazole (BB) inhibitors of MvfR suppress both acute and persistent P. aeruginosa infections in mice without perturbing bacterial growth. Here, we elucidate the crystal structure of the MvfR ligand binding domain (LBD) in complex with one potent BB inhibitor, M64. Structural analysis indicated that M64 binds, like native ligands, to the MvfR hydrophobic cavity. A hydrogen bond and pi interaction were found to be important for MvfR-M64 affinity. Surface plasmon resonance analysis demonstrated that M64 is a competitive inhibitor of MvfR. Moreover, a protein engineering approach revealed that Gln194 and Tyr258 are critical for the interaction between MvfR and M64. Random mutagenesis of the full-length MvfR protein identified a single-amino-acid substitution, I68F, at a DNA binding linker domain that confers M64 insensitivity. In the presence of M64, I68F but not the wild-type (WT) MvfR protein retained DNA binding ability. Our findings strongly suggest that M64 promotes conformational change at the DNA binding domain of MvfR and that the I68F mutation may compensate for this change, indicating allosteric inhibition. This work provides critical new insights into the molecular mechanism of MvfR function and inhibition that could aid in the optimization of anti-MvfR compounds and improve our understanding of MvfR regulation.IMPORTANCEPseudomonas aeruginosa is an opportunistic Gram-negative pathogen that causes serious acute, persistent, and relapsing infections. New approaches to antimicrobial drug discovery are urgently needed to combat intractable infections caused by this pathogen. The Pseudomonas aeruginosa quorum sensing transcription factor MvfR regulates functions important in both acute and persistent infections. We used recently identified inhibitors of MvfR to perform structural studies and reveal important insights that would benefit the optimization of anti-MvfR compounds. Altogether, the results reported here provide critical detailed mechanistic insights into the function of MvfR domains that may benefit the optimization of the chemical, pharmacological, and safety properties of MvfR antagonist series.
Insights
New benzamine-benzimidazole inhibitors target the Multiple Virulence Factor Regulator (MvfR) in Pseudomonas aeruginosa. Structural and genetic studies reveal MvfR allosteric inhibition mechanisms, aiding antimicrobial drug development.
Area of Science:
- Microbiology and Infectious Diseases
- Structural Biology
- Drug Discovery
Background:
- Multidrug-resistant (MDR) bacteria, particularly *Pseudomonas aeruginosa*, pose a significant threat requiring novel antimicrobial strategies.
- The quorum sensing regulator Multiple Virulence Factor Regulator (MvfR) controls virulence factors crucial for both acute and persistent *P. aeruginosa* infections.
- Benzamine-benzimidazole (BB) compounds are emerging as non-ligand-based inhibitors of MvfR, showing efficacy without impacting bacterial growth.
Purpose of the Study:
- To elucidate the structural basis of MvfR inhibition by the BB compound M64.
- To understand the molecular mechanism underlying MvfR inhibition and identify key interaction residues.
- To investigate the potential for allosteric inhibition of MvfR function.
Main Methods:
- Crystal structure determination of the MvfR ligand-binding domain (LBD) complexed with M64.
- Surface Plasmon Resonance (SPR) analysis to assess MvfR-M64 binding kinetics and inhibition type.
- Site-directed mutagenesis and random mutagenesis of MvfR to identify critical residues for inhibitor interaction and resistance.
Main Results:
- M64 binds to the hydrophobic cavity of the MvfR LBD, forming key hydrogen and pi interactions.
- SPR confirmed M64 acts as a competitive inhibitor of MvfR.
- Mutagenesis identified Gln194 and Tyr258 as critical for MvfR-M64 interaction, and an I68F substitution conferred M64 insensitivity by maintaining DNA binding ability.
Conclusions:
- M64 likely induces a conformational change at the MvfR DNA-binding domain, suggesting allosteric inhibition.
- The I68F mutation may act as a compensatory mechanism against MvfR allosteric inhibition.
- These findings provide crucial mechanistic insights for optimizing anti-MvfR drug development against *P. aeruginosa* infections.
More Related Videos
Related Concept Videos
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Competition
Regulation of Expression at Multiple Steps
Master Transcription Regulators
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

